Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
This randomized clinical trial studies if celecoxib will prevent the damaging effects of
sunburn in healthy volunteers. Exposure to ultraviolet light can induce erythema, sunburn or
skin redness caused by inflammation. Celecoxib may reduce skin damage by blocking enzymes
associated with sunburn in healthy volunteers. Studying samples of skin in the laboratory
from patients receiving ultraviolet-radiation before and after celecoxib treatment may help
doctors learn more about the effects celecoxib has on cells.